We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Octopus Group

Sansure Biotech Inc

Sansure Biotech is an integrated solutions manufacturer and provider of diagnostic reagents, nucleic acid diagnostic ... read more Featured Products: More products

Download Mobile App

Sansure Exhibits Portable Molecular Workstation at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 09 Feb 2023
Print article
Image: Sansure is presenting its advanced diagnostics solutions at Medlab Middle East 2023 (Photo courtesy of Sansure)
Image: Sansure is presenting its advanced diagnostics solutions at Medlab Middle East 2023 (Photo courtesy of Sansure)

Sansure Biotech (Hunan, China) is participating as a Platinum Partner at Medlab Middle East 2023 where the company is exhibiting its latest developments in the field of diagnostics. Sansure is also holding two seminars on POCT and blood-borne infections during the first two days of the show taking place live, in-person from 6-9 February 2023.

At the Sansure booth, the focus is on iPonatic III, the new member of the iPonatic series of portable molecular workstations. iPonatic III integrates nucleic acid extraction, PCR amplification, and data analysis into one system. The rich and extendable test menu of Sansure iPonatic III can provide healthcare professionals with fast and accurate results for a wide range of infections, which include RTI, STI, HPV, and other infections. Collocating with prepackaged reagent, iPonatic III is suitable for all scenarios, from large hospitals, primary medical institutions, and fever clinics, to customs, airports and others. Sansure is also highlighting the Natch 48 nucleic acid extraction system that is designed for RNA/DNA extraction and purification. Natch 48 extracts animals and plant tissues, blood and fluid samples, in a rapid, simple, and highly automated way, matching different types of magnetic beads extraction kits. Alongside the Natch 48, Sansure is highlighting the Natch 16S nucleic acid extraction system which is smaller and more portable, on the basis of patented magnetic bar and deep well plate. The Natch 16S works immediately without any other accessory, making it the perfect solution for labs in the post-pandemic era.

Among its advanced diagnostic solutions, Sansure is demonstrating its SARS-CoV-2/Flu/RSV test that enables the detection and differentiation of SARS-CoV-2, flu, and RSV in upper respiratory tract specimens. Sansure is also demonstrating its state-of-the-art solutions to help ensure transfusion safety, including molecular tests for blood NAT screening, and its quantitative tests for HBV, HCV and HIV that can help diagnose disease and monitor viral load. In addition, Sansure is demonstrating its Epstein-Barr virus DNA diagnostic kits for the detection of EBV DNA in peripheral blood, the results of which can be used as an aid in diagnosis of EBV infection and observation of drug efficacy.

Related Links:
Sansure Biotech 

Gold Supplier
ESR Analyzer
Free Triiodothyronine (fT3) Rapid Test
Finecare fT3 Rapid Quantitative Test
Respiratory Syncytial Virus PCR Test
WizDx RSV CrystalMix PCR Kit
Laboratory QC Software
Qualis Interlab

Print article


Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: The new assay enables accurate prognosis and detection data for those prone to esophageal cancer (Photo courtesy of Previse)

First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer

Esophageal cancer is among the most lethal cancers in the world and has a 20% five-year survival rate post-diagnosis. Barrett's esophagus is the sole precursor known and is a significant risk factor for... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Sampling a single stool using multiple PCR panels can identify more pathogens rapidly (Photo courtesy of Pexels)

PCR Panels for Acute GI Infections Can Lower Costs, Hospitalization and Antibiotic Use

Acute gastroenteritis impacts adults across all age groups and incurs enormous healthcare expenses. Now, a new study comprising 40,000 hospital visits across various geographic locations has revealed that... Read more


view channel
Image: Artificial intelligence predicts genetics of cancerous brain tumors in under 90 seconds (Photo courtesy of Michigan Medicine)

AI-Based Diagnostic Screening System Predicts Genetics of Cancerous Brain Tumors in 90 Seconds

The diagnosis and treatment of gliomas increasingly rely on molecular classification, as surgical benefits and risks vary depending on a patient's genetic makeup. Complete removal of the tumor can extend... Read more


view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more


view channel
Image: Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel (Photo courtesy of Roche)

Roche and Eli Lilly Collaborate on Innovative Blood Test for Early Diagnosis of Alzheimer's

Presently, obstacles to timely and precise diagnosis of Alzheimer's disease exist globally, resulting in as many as 75% of individuals exhibiting symptoms but lacking a formal diagnosis.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.